Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells

In recent years, anti-angiogenic therapy has attracted much interest because it is a versatile approach to treating most types of tumors, and therefore would be expected to be applicable for various cancers. Severe adverse events in patients treated with currently available anti-angiogenic therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Hada, Tomoya, Sakurai, Yu, Harashima, Hideyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588203/
https://www.ncbi.nlm.nih.gov/pubmed/26389942
http://dx.doi.org/10.3390/pharmaceutics7030320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588203/
https://www.ncbi.nlm.nih.gov/pubmed/26389942
http://dx.doi.org/10.3390/pharmaceutics7030320

Ejemplares similares